acute coronary syndrome
Advertisement
Antithrombotic therapy with oral anticoagulants (OACs) was associated with reduced risk of ischemic events without ...
A team of researchers, led by Jean Jacques Noubiap, aimed to evaluate the incidence, risk factors, and prognosis of ...
A new high-sensitivity cardiac troponin helps predict adverse cardiovascular events in diabetic patients with critical ...
The use of fractional flow reserve (FFR) combined with optical coherence tomography (OCT) improves the accuracy of ...
In patients with a coronary artery bypass graft (CABG) procedure prior to an acute coronary syndrome, alirocumab added ...
There exists a link between cancer and takotsubo syndrome (TTS) also known as broken heart syndrome, according to a ...
This week's edition features a look at research on the IMPROVE-IT population and a potential benefit for elderly ...
A new analysis suggests that elderly patients may benefit from a high-intensity simvastatin-ezetimibe combination after ...
This week's edition has some news for those who take nutritional supplements to prevent cardiovascular outcomes, a vote ...
A recent analysis of the results of the ODYSSEY OUTCOMES trail suggests that the PCSK9 inhibitor alirocumab added to ...
The digitally supported self-management and self-detection of symptom onset for coronary artery occlusion is feasible, ...
The combination of apixaban and clopidogrel was associated with a reduced risk for bleeding and hospitalization in ...
Depression screening in survivors of acute coronary syndromes (ACS) had no impact on quality of life, according to study ...
Patients on the extreme end of the coronary artery disease spectrum, like those with recurring acute coronary syndrome ...
High-sensitivity C-reactive protein (hsCRP) levels were associated with increased risk for suffering averse cardiac ...
The cholesterol-lowering PCSK9 inhibitor alirocumab reduced the risk for a second heart in patients who had survived ...
A polymer-coated zotarolimus-eluting stent (Resolute Onyx) with a novel thin-strut metallic platform demonstrated ...
The high-density lipoprotein (HDL) mimetic MDCO-216 does not cause plaque regression in statin-treated acute ...
Patients younger than 75 years of age who suffered an MI and were given ticagrelor did not see an increased risk for ...
In patients who recently suffered an acute coronary syndrome (ACS), the PCSK9 inhibitor alirocumab was associated with a ...
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.